Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients

A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease

NCT06055985 ·Status: COMPLETED ·Phase: PHASE2

A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease

NCT04658186 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Safety and Efficacy of KM-819 in Healthy Adults and Participants with Parkinson's Disease

NCT05670782 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Evaluate the Safety and Tolerability of ABBV-0805 in Patients With Parkinson's Disease

NCT04127695 ·Status: WITHDRAWN ·Phase: PHASE1

A Study of MK0657 in Parkinson's Disease Patients (0657-006)

NCT00505843 ·Status: COMPLETED ·Phase: PHASE1

A Randomized, Double-blind, Placebo-controlled Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JX2105 in Healthy Chinese Subjects

NCT06537050 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1

12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/Carbidopa

NCT00456586 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate DNL151 in Subjects With Parkinson's Disease

NCT04056689 ·Status: COMPLETED ·Phase: PHASE1

A Study to Test the Safety, Tolerability, and Blood Levels of UCB0022 in Healthy Participants and Participants With Parkinson's Disease

NCT04867642 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of the Efficacy and Safety of AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease

NCT00986414 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess PDM608 in Healthy Adult Subjects

NCT05950906 ·Status: COMPLETED ·Phase: PHASE1

Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500

NCT01058291 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With Parkinson's Disease

NCT05036473 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Japanese Participants With Parkinson's Disease

NCT03716570 ·Status: TERMINATED ·Phase: PHASE1

Dose-Finding Safety Study of BIIB014 in Combination With Levodopa in Moderate to Late Stage Parkinson's Disease

NCT00438607 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease

NCT03068481 ·Status: COMPLETED ·Phase: PHASE1

PF-06669571 In Subjects With Idiopathic Parkinson's Disease

NCT02565628 ·Status: COMPLETED ·Phase: PHASE1

A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)

NCT00148486 ·Status: COMPLETED ·Phase: PHASE2

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Safety, Tolerability and Efficacy of E2007 in Parkinson's Disease Patients With "Wearing Off" Motor Fluctuations and "On" Period Dyskinesias

NCT01172379 ·Status: COMPLETED ·Phase: PHASE2

A Study to Explore the Safety And Tolerability of Doses of E2007 Up to a Maximum of 8 mg In Patients With Parkinson's Disease Who Experience End-of-Dose Wearing Off Motor Fluctuations

NCT00165789 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2a Study Followed to Evaluate the Safety, Tolerability and Levodopa Pharmacokinetics in Levodopa-treated Parkinson's Disease Patients Receiving ND0612

NCT01883505 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 in Subjects With Idiopathic Parkinson's Disease

NCT02373072 ·Status: COMPLETED ·Phase: PHASE1

A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease

NCT05424276 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease

NCT02006290 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Profile of MT101-5 in Healthy Volunteers

NCT05844787 ·Status: COMPLETED ·Phase: PHASE1